Fumapharm (Royalty interest in BG-12 and Fumaderm) is Buildings and Property in Switzerland that focus on oral therapeutic medicine business. They cover business area such as a portfolio, royalty interest, therapeutic medicine, multiple sclerosis, Fumaderm, severe plaque psoriasis.
-
Oral Therapeutic Medicine
-
Haldenstr. 24a
6006 Lucerne
Switzerland
Private
a portfolioroyalty interesttherapeutic medicinemultiple sclerosisFumadermsevere plaque psoriasis
* We use standard office opening hours in near Fumapharm (Royalty interest in BG-12 and Fumaderm)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Fumapharm (Royalty Interest In BG-12 And Fumaderm) is Buildings and Property business from Switzerland that founded in - ( years old in ), Fumapharm (Royalty interest in BG-12 and Fumaderm) business is focusing on Oral Therapeutic Medicine.
Fumapharm (Royalty interest in BG-12 and Fumaderm) headquarter office and corporate office address is located in Haldenstr. 24a 6006 Lucerne Switzerland.
Fumapharm (Royalty interest in BG-12 and Fumaderm) was founded in Switzerland.
In , Fumapharm (Royalty interest in BG-12 and Fumaderm) is currently focus on oral therapeutic medicine sector.
Above is snippet of Google Trends for "oral therapeutic medicine" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Fumapharm (Royalty interest in BG-12 and Fumaderm), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
